Franklin Resources’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.03M | Sell |
|
|||||
|
2024
Q3 | $2.67M | Buy |
|
|||||
|
2024
Q2 | $1.04M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $120K | Sell |
|
|||||
|
2021
Q2 | $198K | Buy |
|
|||||
|
2021
Q1 | $167K | Sell |
|
|||||
|
2020
Q4 | $1.71M | Buy |
|
|||||
|
2020
Q3 | $125K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $195M | Sell |
|
|||||
|
2019
Q3 | $285M | Sell |
|
|||||
|
2019
Q2 | $569M | Sell |
|
|||||
|
2019
Q1 | $1.01B | Sell |
|
|||||
|
2018
Q4 | $1.02B | Sell |
|
|||||
|
2018
Q3 | $1.43B | Sell |
|
|||||
|
2018
Q2 | $1.76B | Sell |
|
|||||
|
2018
Q1 | $1.25B | Sell |
|
|||||
|
2017
Q4 | $1.51B | Buy |
|
|||||
|
2017
Q3 | $1.29B | Buy |
|
|||||
|
2017
Q2 | $2.22B | Buy |
|
|||||
|
2017
Q1 | $1.93B | Buy |
|
|||||
|
2016
Q4 | $2.05B | Buy |
|
|||||
|
2016
Q3 | $2.16B | Buy |
|
|||||
|
2016
Q2 | $2.07B | Buy |
|
|||||
|
2016
Q1 | $1.97B | Sell |
|
|||||
|
2015
Q4 | $2.69B | Sell |
|
|||||
|
2015
Q3 | $2.71B | Sell |
|
|||||
|
2015
Q2 | $2.96B | Sell |
|
|||||
|
2015
Q1 | $3.43B | Buy |
|
|||||
|
2014
Q4 | $3.15B | Sell |
|
|||||
|
2014
Q3 | $2.96B | Buy |
|
|||||
|
2014
Q2 | $2.88B | Buy |
|
|||||
|
2014
Q1 | $2.6B | Buy |
|
|||||
|
2013
Q4 | $1.73B | Buy |
|
|||||
|
2013
Q3 | $802M | Buy |
|
|||||
|
2013
Q2 | $712M | Buy |
|